Daly Richard J

CIK 00016353934 companiesCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001635393

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2026-01-05+42,105→ 281,843 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2026-01-05−10,577→ 271,266 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-01-05−42,105→ 2,618,539 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+20,006→ 246,800 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−20,006→ 2,661,978 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21−7,872→ 238,928 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+115,283→ 2,681,984 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+381,948→ 2,546,695 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-08-26−50,000→ 2,184,753 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-08-26$2.24/sh+50,000→ 249,764 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-08-26$20.62/sh−22,970→ 226,794 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-05-30$24.86/sh+70,000→ 199,764 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14−1,574→ 269,764 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+4,000→ 271,338 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−4,000→ 2,234,753 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-01-02−42,105→ 2,238,753 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-01-02−10,600→ 267,338 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-01-02+42,105→ 277,938 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−1,333→ 2,280,858 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27−324→ 235,833 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+1,333→ 236,157 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+60,019→ 2,282,191 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+491,160→ 2,222,172 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-06-04$4.01/sh+40,000→ 252,147 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-06-04$15.97/sh−17,323→ 234,824 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-06-04−40,000→ 1,731,012 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-02-15+4,000→ 213,333 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−4,000→ 1,771,012 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-02-15−1,186→ 212,147 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-01-01+1,365,319→ 1,564,486 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-01-01+210,526→ 1,775,012 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−1,333→ 199,167 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+1,333→ 209,333 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-07$1.13/sh+60,000→ 208,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-07−60,000→ 200,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-05-12−50,000→ 260,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-05-12$0.79/sh+50,000→ 148,000 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−5,800→ 2,000 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02−2,500→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−5,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−2,500→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−2,500→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−2,000→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15−4,000→ 310,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15+4,000→ 98,000 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-12-27+15,000→ 310,500 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-27+4,000→ 314,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2022-12-06+1,334→ 94,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2022-12-06−1,334→ 295,500 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2022-08-24−40,000→ 296,834 total

Companies

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov